Available Technology: C12191 - PapGene Test

Johns Hopkins researchers have developed “PapGene” test, a new screening method for endometrial and ovarian cancers. This diagnostic test is easily incorporated into a routine pelvic examination. The invention uses a sequence-based method to query 12 mutations in a single liquid Pap smear. Additionally, this method does not require prior knowledge of the tumor’s genotype. This diagnostic test provides and inexpensive and accurate means of diagnosing ovarian and endometrial cancers.